Hamburg, 17. January 2024 – The Biesterfeld Group has now officially founded the joint venture Biesterfeld Hildose Speciality Chemicals Pvt. Ltd. with its long-standing partner Kersi Tangri, owner of Hildose Pharmaspecialties. With this joint venture, Biesterfeld is creating a strategic and long-term foundation for an active presence in India. Kersi Tangri and Andreas Lekebusch have been appointed Managing Directors and the company is based in Mumbai.
Dirk J. Biesterfeld, Chairman of the Supervisory Board of Biesterfeld AG, explains: "As a family business, we focus on long-term partnerships, shared values and joint growth. We have enjoyed a very trusting and successful partnership with Kersi Tangri for more than 25 years. I am very pleased that we will now intensify this further as part of our joint venture."
Stephan Glander, CEO of the Biesterfeld Group, explains: "The preparations for the establishment of our joint venture have already shown how well our two companies fit together. As partners, we have known each other for many years and have a very trusting relationship. India is a market with enormous potential and offers us great growth prospects together. I would like to thank Kersi Tangri for his trust and Andreas Lekebusch for his excellent work in recent months and look forward to working closely together.”
Kersi Tangri, Managing Director of Biesterfeld Hildose Speciality Chemicals Pvt. Ltd. and owner of Hildose Pharmaspecialties LLP, emphasizes: "We have been active in the Indian market since 1988, trading mainly in active pharmaceutical ingredients, intermediates and specialty chemicals, and have been working successfully with Biesterfeld for more than 25 years. We have a very intensive and trusting partnership, which we are further strengthening through our joint venture. I look forward to continuing to work with Andreas and to being able to offer our suppliers and customers worldwide even more expertise and service with our new setup."
Andreas Lekebusch, Managing Director of Biesterfeld Hildose Speciality Chemicals Pvt. Ltd and Global Business Director of the HealthCare Cluster at Biesterfeld Spezialchemie explains: "I would like to thank Kersi for his trust and look forward to the exciting task and close cooperation. I am sure that with our joint team of highly experienced experts, we have the best conditions for tapping into new growth potential – beyond procurement and distribution in the HealthCare sector into other areas and also other regions such as ASEAN or North and South America."
